SDHB and pituitary cancer: It is interesting that another case with an SDHB-associated pituitary cancer also showed a similar dramatic response to TMZ (24) suggesting an underlying pathogenic mechanism that makes these SDHB-mediated pituitary tumors susceptible to the alkylating agent, TMZ, probably by increasing the proapoptotic or other cytotoxic effects of TMZ.